보도 자료

LVIS Corporation Launches NeuroMatch Pro: AI-Powered Seizure and Spike Detection for Enhanced EEG Diagnostics
Palo Alto, CA – February 6, 2025 – LVIS Corporation has announced the launch of NeuroMatch Pro, an advanced AI-driven platform that builds on the foundation of NeuroMatch to enhance EEG diagnostics. The platform introduces Seizure Detection and Spike Detection, providing powerful tools for the real-time identification and management of seizures and epilepsy-related spike activity. ... Read more

Innovating Epilepsy Care: Highlights from NeuroMatch’s Impact at AES 2024
Each year, the American Epilepsy Society (AES) Annual Meeting brings together the brightest minds in technology for epilepsy, as well as research and treatment. This year, AES 2024 in Los Angeles proved to be an inspiring hub for innovation, collaboration, and discovery. It was an honor for our team at LVIS Corporation to showcase NeuroMatch ... Read more

LVIS Shines at FIX 2024: Pioneering the Future of Brain Health Technology
The Future Innovation Tech Expo (FIX) 2024, held from October 23 to 26 at the Daegu EXCO in South Korea, captured the world’s attention with its expansive display of transformative technologies. With over 463 companies and 2,071 booths under the theme “Better Tech, Better Future,” this event offered a platform to explore future mobility, robotics, ... Read more

LVIS Corporation Signs MOU with Daegu Health College to Foster Next-Generation NeuroMatch Technicians
Palo Alto, CA – November 22, 2024 – LVIS Corporation, an innovator in neural information analysis technology, has signed a Memorandum of Understanding (MOU) with Daegu Health College in South Korea to establish a collaboration for training skilled technicians in the use of NeuroMatch®, LVIS’s cutting-edge AI-driven brain diagnostic technology. This partnership aims to educate ... Read more

LVIS Corporation Launches NeuroMatch® Access: Cloud-Based Platform Revolutionizing EEG Diagnostics
Palo Alto, CA – October 1, 2024– LVIS Corporation, an innovator in neural information analysis technology, has launched NeuroMatch® Access, a cloud-based SaaS platform designed to revolutionize EEG diagnostics by streamlining review and enhancing physician collaboration. This groundbreaking platform, now available to the U.S. market, helps improve clinical workflows allowing neurologists to quickly review and ... Read more

NeuroMatch by LVIS Wins 2024 IMPACT Award for Diagnostic Software of the Year
We are thrilled to announce that NeuroMatch®, LVIS’s revolutionary EEG diagnostic platform, has been recognized with the prestigious 2024 IMPACT Award for Diagnostic Software of the Year. Presented by the Internet Marketing Association (IMA) at their IMPACT5050 conference held at the One & Only Mandarina resort in Mexico, this award highlights NeuroMatch’s significant contribution to ... Read more

Exploring the LVIS NeuroMatch Center in South Korea: Revolutionizing Brain Health and Neuroscience
In June 2024, the world’s first LVIS NeuroMatch Center opened in Daegu, South Korea. This innovative facility is the first educational facility in the world where individuals can experience the groundbreaking NeuroMatch® platform firsthand. As a pivotal development in neuroscience, the NeuroMatch platform is cutting-edge AI-based Software as a Medical Device (SaMD) designed to revolutionize ... Read more

Advancing Brain Health: Insights from the NeuroForum on Epilepsy, Sleep Disorders, and the NeuroMatch Platform
Neurological health is the top cause of disability worldwide, but LVIS Corp is committed to revolutionizing diagnosis and treatment through cutting-edge neural information analysis technology. On June 28, 2024, our company’s recent NeuroForum served as an enlightening platform aimed at educating the public on epilepsy and sleep disorders—two critical areas of brain health that significantly ... Read more
